Cargando…

Immunodominant epitopes based serological assay for detecting SARS-CoV-2 exposure: Promises and challenges

Detalles Bibliográficos
Autor principal:	Quadeer, Ahmed Abdul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Commentary
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7428424/ https://www.ncbi.nlm.nih.gov/pubmed/32807701 http://dx.doi.org/10.1016/j.ebiom.2020.102947

Ejemplares similares

Exploring the Immunodominant Epitopes of SARS-CoV-2 Nucleocapsid Protein as Exposure Biomarker
por: Vashisht, Kapil, et al.
Publicado: (2023)

The immunodominant and neutralization linear epitopes for SARS-CoV-2
por: Lu, Shuai, et al.
Publicado: (2021)

Evaluation of vaccine effectiveness against SARS‐CoV‐2 variants by serological epitope profiling
por: Li, Cheng, et al.
Publicado: (2023)

In silico T cell epitope identification for SARS-CoV-2: Progress and perspectives
por: Sohail, Muhammad Saqib, et al.
Publicado: (2021)

Identification of immunodominant linear epitopes from SARS-CoV-2 patient plasma
por: Farrera-Soler, Lluc, et al.
Publicado: (2020)

SARS-CoV-2 transcriptome analysis and molecular cataloguing of immunodominant epitopes for multi-epitope based vaccine design
por: Kushwaha, Sandeep Kumar, et al.
Publicado: (2020)

Prevalent and immunodominant CD8 T cell epitopes are conserved in SARS-CoV-2 variants
por: Meyer, Saskia, et al.
Publicado: (2023)

Expression and serological application of recombinant epitope-repeat protein carrying an immunodominant epitope of Newcastle disease virus nucleoprotein
por: Gaikwad, Satish S., et al.
Publicado: (2019)

Are Lessons Learned in Setting Cut Points for Detection of Anti-Drug Antibodies Also Useful in Serology Assays for Robust Detection of SARS-CoV-2 Reactive Antibodies?
por: Bowsher, Ronald R., et al.
Publicado: (2020)

Immunoinformatics and Structural Analysis for Identification of Immunodominant Epitopes in SARS-CoV-2 as Potential Vaccine Targets
por: Mukherjee, Sumit, et al.
Publicado: (2020)

Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases
por: Tarke, Alison, et al.
Publicado: (2021)

Searching immunodominant epitopes prior to epidemic: HLA class II-restricted SARS-CoV spike protein epitopes in unexposed individuals
por: Yang, Junbao, et al.
Publicado: (2009)

Evaluation of High-Throughput Serological Tests for SARS-CoV-2
por: Loeffelholz, Michael J.
Publicado: (2020)

RNA interference as a promising treatment against SARS-CoV-2
por: Donia, Ahmed, et al.
Publicado: (2020)

Mapping Immunodominant Antibody Epitopes of Abrin
por: Alcalay, Ron, et al.
Publicado: (2020)

Comparison of Serological Assays for the Detection of SARS-CoV-2 Antibodies
por: James, Joe, et al.
Publicado: (2021)

The paramount importance of serological surveys of SARS-CoV-2 infection and immunity
por: Goudsmit, Jaap
Publicado: (2020)

A serological assay to detect SARS-CoV-2 seroconversion in humans
por: Amanat, Fatima, et al.
Publicado: (2020)

A serological assay to detect human SARS-CoV-2 antibodies
por: Mahallawi, Waleed H.
Publicado: (2020)

Comparison of Five Serological Assays for the Detection of SARS-CoV-2 Antibodies
por: Dörschug, Anja, et al.
Publicado: (2021)

Renaming the SARS‐CoV‐2 Omicron sublineages as SARS‐CoV‐3 is contrary to nomenclature standards based on evolutionary and serological evidence
por: Qi, Zhongtian, et al.
Publicado: (2022)

Parallel detection of SARS‐CoV‐2 epitopes reveals dynamic immunodominance profiles of CD8 (+) T memory cells in convalescent COVID‐19 donors
por: van den Dijssel, Jet, et al.
Publicado: (2022)

CD8(+) T cells specific for an immunodominant SARS-CoV-2 nucleocapsid epitope cross-react with selective seasonal coronaviruses
por: Lineburg, Katie E., et al.
Publicado: (2021)

Immunodominant linear B cell epitopes in the spike and membrane proteins of SARS-CoV-2 identified by immunoinformatics prediction and immunoassay
por: Polyiam, Kanokporn, et al.
Publicado: (2021)

Monoclonal antibodies targeting two immunodominant epitopes on the Spike protein neutralize emerging SARS-CoV-2 variants of concern
por: Kovacech, Branislav, et al.
Publicado: (2022)

Mapping Neutralizing and Immunodominant Sites on the SARS-CoV-2 Spike Receptor-Binding Domain by Structure-Guided High-Resolution Serology
por: Piccoli, Luca, et al.
Publicado: (2020)

On the importance of population-based serological surveys of SARS-CoV-2 without overlooking their inherent uncertainties
por: Kritsotakis, Evangelos I.
Publicado: (2020)

SARS-CoV-2 Multi-Antigen Serology Assay
por: Mazhari, Ramin, et al.
Publicado: (2021)

Dm Determines the Cryptic and Immunodominant Fate of T Cell Epitopes
por: Nanda, Navreet K., et al.
Publicado: (2000)

Characterization of an Immunodominant Epitope in the Endodomain of the Coronavirus Membrane Protein
por: Dong, Hui, et al.
Publicado: (2016)

The Relative Positioning of B and T Cell Epitopes Drives Immunodominance
por: Biavasco, Riccardo, et al.
Publicado: (2022)

LBA73 The ORF1ab of SARS-CoV-2 encodes an immunodominant epitope restricted by HLA-A*01:01
por: Kvistborg, P., et al.
Publicado: (2020)

Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein
por: Chaurasia, Priyanka, et al.
Publicado: (2021)

Surveillance of SARS-CoV-2 immunogenicity: loss of immunodominant HLA-A*02-restricted epitopes that activate CD8(+) T cells
por: Lopes-Ribeiro, Ágata, et al.
Publicado: (2023)

Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope
por: Rouvinski, Alexander, et al.
Publicado: (2017)

Extracellular vesicles: A promising therapy against SARS-CoV-2 infection
por: Leyfman, Yan, et al.
Publicado: (2023)

SARS-CoV-2 diagnostics: Some reflections on current assays
por: Antonelli, Guido, et al.
Publicado: (2021)

A novel precision-serology assay for SARS-CoV-2 infection based on linear B-cell epitopes of Spike protein
por: Lundin, Samuel B., et al.
Publicado: (2023)

Epitope-Specific Serological Assays for RSV: Conformation Matters
por: Phung, Emily, et al.
Publicado: (2019)

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies
por: Ahmed, Syed Faraz, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ifb2gflktuvo5sm0le6q5lcebg